Literature DB >> 16928996

Clinical practice. Heparin-induced thrombocytopenia.

Gowthami M Arepally1, Thomas L Ortel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928996     DOI: 10.1056/NEJMcp052967

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  95 in total

1.  Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

Authors:  Jessica A Reese; Xiaoning Li; Manfred Hauben; Richard H Aster; Daniel W Bougie; Brian R Curtis; James N George; Sara K Vesely
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

2.  The zebra in the room.

Authors:  Grace Lee
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

3.  Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities.

Authors:  Yongmei Xu; Elizabeth H Pempe; Jian Liu
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

4.  Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia.

Authors:  Nicole L Whitlatch; David F Kong; Ara D Metjian; Gowthami M Arepally; Thomas L Ortel
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

5.  Acute respiratory distress and hemorrhagic shock in a patient 12 days after elective hepatic surgery.

Authors:  Nektaria Xirouchaki; Eleni Mavrogeni; Eumorfia Kondili; Dimitris Georgopoulos
Journal:  Intensive Care Med       Date:  2006-12-13       Impact factor: 17.440

Review 6.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

7.  Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.

Authors:  John R Bartholomew; Carolynn E Pietrangeli; Marcie J Hursting
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 8.  Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.

Authors:  E Marc Jolicoeur; Tracy Wang; Renato D Lopes; E Magnus Ohman
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

9.  Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.

Authors:  Rustem I Litvinov; Serge V Yarovoi; Lubica Rauova; Valeri Barsegov; Bruce S Sachais; Ann H Rux; Jillian L Hinds; Gowthami M Arepally; Douglas B Cines; John W Weisel
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

10.  Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience.

Authors:  Christopher Ruslan Hayes; David Keane
Journal:  J Interv Card Electrophysiol       Date:  2010-03       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.